Analyst Price Targets — CERT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 12, 2026 1:18 pm | — | Craig-Hallum | $8.00 | $5.03 | TheFly | Certara price target lowered to $8 from $10 at Craig-Hallum |
| February 26, 2026 6:08 pm | Michael Cherny | Leerink Partners | $10.00 | $6.61 | StreetInsider | Certara Inc. (CERT) PT Lowered to $10 at Leerink Partners |
| January 6, 2026 12:33 pm | Certara to Outperform | Leerink Partners | $13.00 | $9.04 | TheFly | Certara upgraded to Outperform from Market Perform at Leerink |
| November 21, 2025 9:45 am | — | Redburn Partners | $10.00 | $8.03 | TheFly | Certara initiated with a Buy at Rothschild & Co Redburn |
| September 29, 2025 11:13 am | — | Craig-Hallum | $16.00 | $11.80 | TheFly | Certara initiated with a Buy at Craig-Hallum |
| November 5, 2024 11:50 am | Joe Vruwink | Robert W. Baird | $13.00 | $10.31 | StreetInsider | Certara Inc. (CERT) PT Lowered to $13 at Baird |
| September 27, 2024 5:22 am | Dan Leonard | UBS | $16.00 | $10.70 | TheFly | Certara upgraded to Buy from Neutral at UBS |
| June 28, 2024 5:28 am | Luke Sergott | Barclays | $16.00 | $13.65 | TheFly | Certara price target lowered to $16 from $18 at Barclays |
| April 10, 2024 1:31 am | Scott Schoenhaus | KeyBanc | $23.00 | $18.51 | StreetInsider | KeyBanc Upgrades Certara Inc. (CERT) to Overweight |
| November 14, 2022 7:29 am | — | Credit Suisse | $20.00 | $14.65 | Benzinga | Credit Suisse Maintains Outperform on Certara, Lowers Price Target to $20 |
Latest News for CERT
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CERT.
U.S. House Trading
No House trades found for CERT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.